Covid-19: Joint statement from the ABS & UKBCG on Neoadjuvant Chemotherapy
The UKBCG and ABS released a joint statement on neoadjuvant chemotherapy during the Covid-19 pandemic
ABS & UKBCG | UK
15.05.2020
Added: 15.05.2020
Classifications: Service Guidance
Keywords: Neoadjuvant Chemotherapy/ NACT COVID-19